Michigan Institute of Urology, PC

Troy, Michigan 48084

2 studies enrolling now · 16 studies all time

What they study most

Adenocarcinoma of the Prostate, Advanced Prostate Cancer, Bladder Cancer, Cancer of the Prostate, Cystitis, Interstitial, Hormone Sensitive Prostate Cancer, Lung Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Non Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Non-muscle Invasive Bladder Cancer, Non-muscle Invasive Bladder Cancer (NMIBC)

Studies at this site

• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. — Recruiting now
• A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy — Running, not enrolling
• A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT — Running, not enrolling
• A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder — Completed
• A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases — Completed
• An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG — Available (expanded access)
• A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer — Running, not enrolling
• Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer — Completed
• Lung EpiCheck Biomarkers Development Study — Status unconfirmed
• A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome — Stopped early
• The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma — Completed
• Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure — Completed
• Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) — Completed
• Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC — Stopped early
• Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence — Completed
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed